Cargando…

Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents

PURPOSE: The purpose of this study was to assess and compare diagnostic ability of LI-RADS (LR) v. 2017 and ESGAR guidelines in hepatocellular carcinoma (HCC) diagnosis using MRI with hepatobiliary contrast agents. METHODS: Seventy pathologically confirmed lesions in 32 patients (24 males and 8 fema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosiak, Grzegorz, Podgorska, Joanna, Rosiak, Edyta, Cieszanowski, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076943/ https://www.ncbi.nlm.nih.gov/pubmed/30105242 http://dx.doi.org/10.1155/2018/7465126

Ejemplares similares

CT/MRI LI-RADS v2017 – review of the guidelines
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization
por: Bartnik, Krzysztof, et al.
Publicado: (2021)

Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC)
por: Cieszanowski, Andrzej, et al.
Publicado: (2016)

ESGAR 2017 Book of Abstracts
Publicado: (2017)

Ultrasound-guided percutaneous aspiration of adventitial cysts in the occluded popliteal artery – clinical results and MR findings at 5-year follow-up
por: Rosiak, Grzegorz, et al.
Publicado: (2017)

Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study
por: Bartnik, Krzysztof, et al.
Publicado: (2021)

Making useful clinical guidelines: the ESGAR perspective
por: Plumb, A. A. O., et al.
Publicado: (2019)

ESGAR Book of Abstracts
Publicado: (2013)

Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC
por: Wen, Rong, et al.
Publicado: (2023)

MRI with hepatobiliary contrast
por: Jhaveri, Kartik S
Publicado: (2015)

ESGAR 2014 Book of Abstracts
Publicado: (2014)

ESGAR 2012 Book of Abstracts
Publicado: (2012)

ESGAR 2011 Book of Abstracts
Publicado: (2011)

ESGAR 2015 Book of Abstracts
Publicado: (2015)

ESGAR 2016 Book of Abstracts
Publicado: (2016)

ESGAR 2019 Book of Abstracts
Publicado: (2019)

ESGAR 2008 - Book of Abstracts
Publicado: (2008)

ESGAR 2020 Book of Abstracts
Publicado: (2020)

ESGAR 2021 Book of Abstracts
Publicado: (2021)

ESGAR 2022 Book of Abstracts
Publicado: (2022)

ESGAR 2023 Book of Abstracts
Publicado: (2023)

An X-ray lead screen may be used to reduce an interventional radiologist’s radiation exposure during CT-guided procedures
por: Rosiak, Grzegorz, et al.
Publicado: (2022)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update
por: Granata, Vincenza, et al.
Publicado: (2017)

LI-RADS ancillary features on contrast-enhanced ultrasonography
por: Dietrich, Christoph F., et al.
Publicado: (2020)

ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
por: Neri, E., et al.
Publicado: (2015)

The second ESGAR consensus statement on CT colonography
por: Neri, Emanuele, et al.
Publicado: (2012)

CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners
por: Patella, Francesca, et al.
Publicado: (2018)

Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE
por: Foley, Kieran G., et al.
Publicado: (2021)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients
por: Braat, Manon N. G. J. A., et al.
Publicado: (2017)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

LI-RADS v2017 for liver nodules: how we read and report
por: Schima, Wolfgang, et al.
Publicado: (2018)

Summary of radiation dose management and optimization: comparison of radiation protection measures between Poland and other countries
por: Jasieniak, Jakub, et al.
Publicado: (2023)

Liver Imaging and Hepatobiliary Contrast Media
por: Pastor, Catherine M., et al.
Publicado: (2018)

Diagnostic Performance of LI-RADS v2018 versus KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging with Hepatobiliary Agent: A Systematic Review and Meta-Analysis of Comparative Studies
por: Shin, Jaeseung, et al.
Publicado: (2023)

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
por: Kim, Tae Kyoung, et al.
Publicado: (2017)

Time-resolved contrast-enhanced MR angiography: Value of hemodynamic information in the assessment of vascular diseases
por: Maj, Edyta, et al.
Publicado: (2010)

Contrast Enhanced MRI in the Diagnosis of HCC
por: Niendorf, Eric, et al.
Publicado: (2015)

Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors
por: Ryeom, Hunkyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l6mkqfl8egc3qutcvd4i0jn5fe